The Cornea research team at VERU was awarded the ‘Best paper prize’ at the EUCORNEA meeting in Amsterdam on the 4th October 2013. The award was received by Dr Heidi Aichner, Corneal fellow who presented the results of the human corneal penetration and anterior chamber concentration of topical antifungal agents to the research and clinical audience. The prospective randomized trial was led by Professor Rajan based at VERU in conjunction with Cambridge Eye Unit, Addenbrooke’s Hospital and Microbiology Services Division, HPA South West Laboratory, Bristol.
The project utilized the previously established In vitro human corneal model at VERU to show significant variations in bioavailability between various anti-fungal agents, thereby explaining the poor clinical response seen in certain types of mycotic keratitis. The judging panel of EUCORNEA meeting commended the research as having significant translational value and vital to the understanding of clinical responses to topical anti-fungals in resistant and often vision threatening fungal corneal infections.
Professor Rajan commented that ‘We are very pleased to receive recognition of our research from EUCORNEA and congratulated the team and collaborators for their contribution. The corneal research team continues to make progress in corneal therapeutics to optimize management of such severe blinding infections.